Friday, March 1, 2024 |
FOLLOW US:

Exclusive: Rockville biotech expanding, ‘on the prowl’ for talent ahead of planned IPO

March 18, 2022

Rockville’s Immunomic Therapeutics Inc. is on track to go public later this year, after Covid-19 threw a wrench in the vaccine maker’s initial timeline. But a few things must happen first. So while juggling clinical trials, the immunotherapy company is hiring aggressively, expanding its Montgomery County footprint and eyeing more funding ahead of an initial public offering slated for the second half of this year.

Article Source: Washington Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.